A coalition of institutions from life sciences, technology and philanthropy launched a new campaign called “The Fight Is In Us,” seeking COVID-19 survivors to donate plasma containing antibodies for transfusions… Read More
Despite a potential vaccine, the novel coronavirus could return on a seasonal basis, much like the flu, according to Seattle-based company Adaptive Biotechnologies. That’s one of the reasons Adaptive is… Read More
Alder BioPharmaceuticals has raised $170 million in a stock offering and is ramping up operations after filing an FDA application for eptinezumab, a therapy for patients with chronic migraines. Alder… Read More
Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition to the up-front payment, Adaptive could receive up to $2… Read More
Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got a boost from the FDA. The company’s leading drug, called… Read More